AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24272023 — intervention group
Group type: EXPERIMENTAL
Intervention: Interrupted mattress suture (group I)
Number of subjects: 130
Study 24272023 — intervention group
Group type: COMPARATOR
Intervention: Subcuticular suture (group II)
Number of subjects: 130
Study 23732051 — intervention group
Group type: EXPERIMENTAL
Intervention: Flucloxacillin 500 mg four times daily and phenoxymethylpenicillin 500 mg four times daily (dual therapy)
Number of subjects: 172
Study 23732051 — intervention group
Group type: COMPARATOR
Intervention: Flucloxacillin 500 mg four times daily (monotherapy)
Number of subjects: 172
Study 20576631 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine infusion in 23 patients (Group NOR)
Number of subjects: 44
Study 20576631 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine (max. 10 mg) administered in 21 patients (Group EPH)
Number of subjects: 44
Study 20576631 — intervention group
Group type: COMPARATOR
Intervention: Normal volunteers (11 subjects)
Number of subjects: 44
Study 18378520 — intervention group
Group type: COMPARATOR
Intervention: Ramipril (10 mg per day)
Number of subjects: 25620
Study 18378520 — intervention group
Group type: COMPARATOR
Intervention: Telmisartan (80 mg per day)
Number of subjects: 25620
Study 18378520 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy (ramipril + telmisartan)
Number of subjects: 25620
Study 15086766 — intervention group
Group type: EXPERIMENTAL
Intervention: Cohesive short-stretch system (Actico, Activa Healthcare)
Number of subjects: 156
Study 15086766 — intervention group
Group type: COMPARATOR
Intervention: Four-layer bandage system
Number of subjects: 156
Study 15086766 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 156
Study 11434703 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary n-3 fatty acids (0.1 g/kg/d as menhaden fish oil containing 12% EPA and 18% DHA)
Number of subjects: 10
Study 11434703 — intervention group
Group type: COMPARATOR
Intervention: Control dietary olive oil
Number of subjects: 10
Study 11434703 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary n-3 fatty acids
Number of subjects: 10
Study 9931626 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant radio- and/or chemotherapy
Number of subjects: 0
Study 9931626 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-field lymphadenectomy
Number of subjects: 0
Study 9931626 — intervention group
Group type: COMPARATOR
Intervention: Two-field lymphadenectomy
Number of subjects: 0
Study 8311283 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% gelatin in electrolyte solution
Number of subjects: 34
Study 8311283 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline 0.9%
Number of subjects: 34
Study 2969537 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous sutures
Number of subjects: 40
Study 2969537 — intervention group
Group type: COMPARATOR
Intervention: Interrupted sutures
Number of subjects: 40
Study 31563386 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID therapy
Number of subjects: 84
Study 31563386 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping
Number of subjects: 84
Study 31563386 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham taping with NSAID therapy
Number of subjects: 84
Study 27154871 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Qing'e Pill (MQEP)
Number of subjects: 96
Study 27154871 — intervention group
Group type: COMPARATOR
Intervention: Simulated pills (Control)
Number of subjects: 96
Study 25146720 — intervention group
Group type: COMPARATOR
Intervention: CHOP chemotherapy
Number of subjects: 46
Study 25146720 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOP + bortezomib chemotherapy
Number of subjects: 46
Study 22864529 — intervention group
Group type: EXPERIMENTAL
Intervention: Open mouth position
Number of subjects: 20
Study 22864529 — intervention group
Group type: EXPERIMENTAL
Intervention: Rubber dam with mouth open
Number of subjects: 20
Study 22864529 — intervention group
Group type: COMPARATOR
Intervention: Mouth closed
Number of subjects: 20
Study 21236451 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin treatment
Number of subjects: 23
Study 21236451 — intervention group
Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 23
Study 18551362 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritual Meditation
Number of subjects: 83
Study 18551362 — intervention group
Group type: COMPARATOR
Intervention: Internally Focused Secular Meditation
Number of subjects: 83
Study 18551362 — intervention group
Group type: COMPARATOR
Intervention: Externally Focused Secular Meditation
Number of subjects: 83
Study 18551362 — intervention group
Group type: COMPARATOR
Intervention: Muscle Relaxation
Number of subjects: 83
Study 16439046 — intervention group
Group type: EXPERIMENTAL
Intervention: One visit Endodontic procedure
Number of subjects: 112
Study 16439046 — intervention group
Group type: COMPARATOR
Intervention: Two visit Endodontic procedure
Number of subjects: 112
Study 16439046 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (one and two visits)
Number of subjects: 112
Study 12646296 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced care for females
Number of subjects: 0
Study 12646296 — intervention group
Group type: COMPARATOR
Intervention: Usual care for females
Number of subjects: 0
Study 12646296 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced care for males
Number of subjects: 0
Study 12646296 — intervention group
Group type: COMPARATOR
Intervention: Usual care for males
Number of subjects: 0
Study 10845730 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam 2000 mg daily
Number of subjects: 119
Study 10845730 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam 4000 mg daily
Number of subjects: 119
Study 10845730 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study 10845730 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo to Levetiracetam 4000 mg daily
Number of subjects: 119
Study 10845730 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam 2000 mg daily (initiated)
Number of subjects: 119
Study 10845730 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label phase (Levetiracetam 4000 mg daily)
Number of subjects: 119
Study 9350938 — intervention group
Group type: EXPERIMENTAL
Intervention: <5 repetitive ventricular responses
Number of subjects: 149
Study 9350938 — intervention group
Group type: COMPARATOR
Intervention: <16 repetitive ventricular responses
Number of subjects: 149
Study 8416081 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard tone stimuli at frequencies of 250, 1,000, or 4,000 Hz
Number of subjects: 0
Study 8416081 — intervention group
Group type: EXPERIMENTAL
Intervention: Deviant tone stimuli (10% higher frequency than standards)
Number of subjects: 0
Study 8416081 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency dependence of MMNm source
Number of subjects: 0
Study 3513587 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone vaginal suppositories (200 mg in polyethylene glycol base), self-administered twice daily for a minimum of 12 days before menstruation for 3 months
Number of subjects: 20
Study 3513587 — intervention group
Group type: COMPARATOR
Intervention: Placebo, self-administered twice daily for a minimum of 12 days before menstruation for 3 months
Number of subjects: 20
Study 31835649 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal postal invitation letter
Number of subjects: 0
Study 31835649 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal postal invitation letter with one reminder letter
Number of subjects: 0
Study 31835649 — intervention group
Group type: COMPARATOR
Intervention: Current screening practice (control)
Number of subjects: 0
Study 30341135 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia
Number of subjects: 1032
Study 30341135 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 1032
Study 27348693 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative group (arthroscopic acromioplasty followed by structured exercise program)
Number of subjects: 140
Study 27348693 — intervention group
Group type: COMPARATOR
Intervention: Structured exercise group (non-operative treatment)
Number of subjects: 140
Study 24991044 — intervention group
Group type: EXPERIMENTAL
Intervention: 25,000 IU neonatal vitamin A
Number of subjects: 6048
Study 24991044 — intervention group
Group type: EXPERIMENTAL
Intervention: 50,000 IU neonatal vitamin A
Number of subjects: 6048
Study 24991044 — intervention group
Group type: COMPARATOR
Intervention: Any dose of neonatal vitamin A (NVAS)
Number of subjects: 6048
Study 24991044 — intervention group
Group type: COMPARATOR
Intervention: NVAS (any dose)
Number of subjects: 6048
Study 24991044 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6048
Study 22704229 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TNA) administered preoperatively (1 g 10 minutes before surgery)
Number of subjects: 107
Study 22704229 — intervention group
Group type: COMPARATOR
Intervention: Tranexamic Acid (TNA) administered postoperatively
Number of subjects: 107
Study 22704229 — intervention group
Group type: COMPARATOR
Intervention: Control group (no TNA administration)
Number of subjects: 107
Study 22704229 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TNA) administered at different times during the procedure
Number of subjects: 107
Study 20826629 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured exercise (EX)
Number of subjects: 100
Study 20826629 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 100
Study 19093655 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid palatal expansion (RPE) therapy
Number of subjects: 41
Study 15746261 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO) at 5 ppm
Number of subjects: 274
Study 15746261 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonhypoxemic infants)
Number of subjects: 274
Study 11897289 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative descriptions of drug side-effects
Number of subjects: 750
Study 11897289 — intervention group
Group type: COMPARATOR
Intervention: Quantitative descriptions of drug side-effects
Number of subjects: 750
Study 9660282 — intervention group
Group type: COMPARATOR
Intervention: Prochlorperazine 10 mg i.v.
Number of subjects: 64
Study 9660282 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 30 mg i.v.
Number of subjects: 64
Study 8073244 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis administered by nurses
Number of subjects: 0
Study 8073244 — intervention group
Group type: COMPARATOR
Intervention: Conventional oral medication combined with nerve blocks and/or spinal administration of drugs
Number of subjects: 0
Study 2817597 — intervention group
Group type: EXPERIMENTAL
Intervention: LY171883 600 mg twice a day
Number of subjects: 20
Study 2817597 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 4901346 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferro-Gradume (slow-release preparation of ferrous sulphate)
Number of subjects: 0
Study 4901346 — intervention group
Group type: COMPARATOR
Intervention: Ferrous fumarate (single daily dose regimen)
Number of subjects: 0
Study 30920094 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-affirmation
Number of subjects: 0
Study 30920094 — intervention group
Group type: EXPERIMENTAL
Intervention: Other-affirmation
Number of subjects: 0
Study 30920094 — intervention group
Group type: COMPARATOR
Intervention: No-affirmation (Control)
Number of subjects: 0
Study 28325784 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 1,100 mg myo‐inositol, 27.6 mg D‐chiro‐inositol, and 400 μg folic acid
Number of subjects: 240
Study 28325784 — intervention group
Group type: COMPARATOR
Intervention: 400 μg folic acid only
Number of subjects: 240
Study 25163832 — intervention group
Group type: EXPERIMENTAL
Intervention: If-then plans for mobility-related goals
Number of subjects: 20
Study 25163832 — intervention group
Group type: COMPARATOR
Intervention: Control group (no if-then plans)
Number of subjects: 20
Study 23478199 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided surgery (USS)
Number of subjects: 0
Study 23478199 — intervention group
Group type: COMPARATOR
Intervention: Palpation-guided surgery (PGS)
Number of subjects: 0
Study 22212270 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training program (walking and jogging) for 12 weeks
Number of subjects: 40
Study 22212270 — intervention group
Group type: COMPARATOR
Intervention: Non-exercising control group
Number of subjects: 40
Study 18165566 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 2 mg/kg
Number of subjects: 340
Study 18165566 — intervention group
Group type: COMPARATOR
Intervention: Thiopental 5 mg/kg
Number of subjects: 340
Study 16984988 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide LAR (20 mg)
Number of subjects: 29
Study 16984988 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline injections)
Number of subjects: 29
Study 12875418 — intervention group
Group type: EXPERIMENTAL
Intervention: LocaLisa system
Number of subjects: 50
Study 12875418 — intervention group
Group type: COMPARATOR
Intervention: Conventional fluoroscopy-based approach
Number of subjects: 50
Study 16972594 — intervention group
Group type: EXPERIMENTAL
Intervention: Batroxobin (1.0 ml (10BU) on days 1, 3, and 5; 0.5 ml (5BU) on days 7 and 9)
Number of subjects: 90
Study 16972594 — intervention group
Group type: COMPARATOR
Intervention: Standard (basic) therapy
Number of subjects: 90
Study 10577646 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine‐123‐labelled iodoamphetamine single‐photon emission computed tomography
Number of subjects: 0
Study 8742957 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuEpo therapy during dialysis
Number of subjects: 91
Study 8742957 — intervention group
Group type: COMPARATOR
Intervention: No rHuEpo therapy during dialysis
Number of subjects: 91
Study 1892775 — intervention group
Group type: EXPERIMENTAL
Intervention: 3M (mitomycin C 7‐8 mg m‐2, mitozantrone 7‐8 mg m‐2, methotrexate 35 mg m‐2)
Number of subjects: 217
Study 1892775 — intervention group
Group type: COMPARATOR
Intervention: VAC (vincristine 1.4 mg m‐2, anthracycline 30 mg m‐2, cyclophosphamide 400 mg m‐2)
Number of subjects: 217
Study 1892775 — intervention group
Group type: EXPERIMENTAL
Intervention: 3M
Number of subjects: 217
Study 6638442 — intervention group
Group type: EXPERIMENTAL
Intervention: Althesin
Number of subjects: 120
Study 6638442 — intervention group
Group type: EXPERIMENTAL
Intervention: methohexitone
Number of subjects: 120
Study 31889508 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily preventive zinc dispersible tablets (PZ; 7 mg zinc)
Number of subjects: 3407
Study 31889508 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily multiple micronutrient powders (MNP; 10 mg zinc, 6 mg iron, and 13 other micronutrients)
Number of subjects: 3407
Study 31889508 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic zinc supplements for diarrhea treatment (TZ; 20 mg/day for 10 days)
Number of subjects: 3407
Study 31889508 — intervention group
Group type: COMPARATOR
Intervention: Daily placebo powder
Number of subjects: 3407
Study 29290273 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral program (reading an educational photo book and watching a music video)
Number of subjects: 68
Study 29290273 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cognitive-behavioral program)
Number of subjects: 68
Study 29290273 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral program
Number of subjects: 68
Study 26409729 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital pleural drainage device
Number of subjects: 172
Study 26409729 — intervention group
Group type: COMPARATOR
Intervention: Analog pleural drainage device
Number of subjects: 172
Study 24972577 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese medicine (CM) decoction based on syndrome differentiation
Number of subjects: 406
Study 24972577 — intervention group
Group type: COMPARATOR
Intervention: Phenolphthalein Tablet (Control)
Number of subjects: 406
Study 24972577 — intervention group
Group type: COMPARATOR
Intervention: Both groups (CM and Control)
Number of subjects: 406
Study 21753728 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and AA (EAA)
Number of subjects: 51
Study 21753728 — intervention group
Group type: COMPARATOR
Intervention: Exercise Alone (E)
Number of subjects: 51
Study 19608563 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2%
Number of subjects: 65
Study 19608563 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 0.4%
Number of subjects: 65
Study 17894656 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (20 mg/kg/day)
Number of subjects: 43
Study 17894656 — intervention group
Group type: COMPARATOR
Intervention: Untreated (control group)
Number of subjects: 43
Study 15133359 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrophysiology catheter aided positioning strategy (EPA)
Number of subjects: 34
Study 15133359 — intervention group
Group type: COMPARATOR
Intervention: Guiding catheter alone positioning strategy (GCA)
Number of subjects: 34
Study 12411650 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture with stroke rehabilitation
Number of subjects: 1213
Study 12411650 — intervention group
Group type: COMPARATOR
Intervention: Real acupuncture
Number of subjects: 1213
Study 12411650 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture without stroke rehabilitation
Number of subjects: 1213
Study 9849757 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforced pelvic floor muscle exercises (PFME) with physiotherapist instruction
Number of subjects: 230
Study 9849757 — intervention group
Group type: COMPARATOR
Intervention: Standard postnatal pelvic floor muscle exercises
Number of subjects: 230
Study 8006248 — intervention group
Group type: EXPERIMENTAL
Intervention: Brofaromine
Number of subjects: 51
Study 8006248 — intervention group
Group type: COMPARATOR
Intervention: Lithium addition to maprotiline
Number of subjects: 51
Study 2593866 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 17 beta-oestradiol (E2) applied twice daily for 45-50 days at concentrations of 0.1 mg/g and 1.0 mg/g
Number of subjects: 8
Study 2593866 — intervention group
Group type: COMPARATOR
Intervention: Placebo applied twice daily for 45-50 days
Number of subjects: 8
Study 30925498 — intervention group
Group type: EXPERIMENTAL
Intervention: Add-on citalopram (30 mg/d)
Number of subjects: 104
Study 30925498 — intervention group
Group type: COMPARATOR
Intervention: Add-on lithium (adjusted to plasma levels)
Number of subjects: 104
Study 29190863 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity Program (PAP) - 3 months, 5 days a week, 45 minutes each day
Number of subjects: 22
Study 29190863 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PAP)
Number of subjects: 22
Study 25758426 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed whey formula with L reuteri (PRO)
Number of subjects: 122
Study 25758426 — intervention group
Group type: COMPARATOR
Intervention: Partially hydrolyzed whey formula without L reuteri (CON)
Number of subjects: 122
Study 23346990 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg once daily for 12 weeks
Number of subjects: 511
Study 23346990 — intervention group
Group type: COMPARATOR
Intervention: Tamsulosin 0.4 mg once daily for 12 weeks
Number of subjects: 511
Study 23346990 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 511
Study 21482964 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose multivitamin (folic acid, vitamin B6, and vitamin B12)
Number of subjects: 4110
Study 21482964 — intervention group
Group type: COMPARATOR
Intervention: Low-dose multivitamin (folic acid, vitamin B6, and vitamin B12)
Number of subjects: 4110
Study 20382685 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (100 mg/d)
Number of subjects: 175
Study 20382685 — intervention group
Group type: COMPARATOR
Intervention: Diabetic patients
Number of subjects: 175
Study 17971602 — intervention group
Group type: EXPERIMENTAL
Intervention: New therapy
Number of subjects: 0
Study 17971602 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 0
Study 16272869 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard antituberculous chemotherapy for 6 or 12 months
Number of subjects: 56
Study 12171372 — intervention group
Group type: EXPERIMENTAL
Intervention: Family intervention (single family therapy)
Number of subjects: 0
Study 12171372 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 0
Study 12171372 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study 12171372 — intervention group
Group type: COMPARATOR
Intervention: Other active interventions
Number of subjects: 0
Study 10187880 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal rheopheresis
Number of subjects: 33
Study 10187880 — intervention group
Group type: COMPARATOR
Intervention: Control (no extracorporeal rheopheresis)
Number of subjects: 33
Study 7482410 — intervention group
Group type: EXPERIMENTAL
Intervention: aprotinin treatment (A)
Number of subjects: 16
Study 7482410 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 16
Study 2405506 — intervention group
Group type: EXPERIMENTAL
Intervention: HCG injections
Number of subjects: 40
Study 2405506 — intervention group
Group type: COMPARATOR
Intervention: Placebo injections (saline)
Number of subjects: 40
Study 2405506 — intervention group
Group type: EXPERIMENTAL
Intervention: HCG injections and Placebo injections
Number of subjects: 40
Study 6159391 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin (0.025 mg/h)
Number of subjects: 6
Study 30521662 — intervention group
Group type: EXPERIMENTAL
Intervention: Short dental implants
Number of subjects: 46
Study 30521662 — intervention group
Group type: COMPARATOR
Intervention: Conventional dental implants
Number of subjects: 46
Study 27477476 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (patient‐practitioner communication training)
Number of subjects: 184
Study 27477476 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 184
Study 25588294 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline (active pill plus placebo patch)
Number of subjects: 1246
Study 25588294 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch (active patch plus placebo pill)
Number of subjects: 1246